Pfizer (NYSE:PFE)

Merrill Lynch Has 5 Income Portfolio Stocks to Buy With Big-Time Dividends

It has become pretty obvious that interest rates are going nowhere this year, and they may not go anywhere in 2020 either. The Federal Reserve is worried about slowing growth, ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Apple Overtakes Pfizer as Most Shorted Dow Stock

It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or ...
Read Full Story »

2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure

It may seem like a time of uncertainty for companies producing drugs if they have to include the prices if they advertise those drugs to the public. Some companies always will ...
Read Full Story »

Why Pfizer Shareholders Are Smiling After Earnings

When Pfizer Inc. (NYSE: PFE) reported first-quarter 2019 results before markets opened Tuesday, the drugmaker posted adjusted diluted earnings per share (EPS) of $0.85 on revenues of $13.12 billion. In ...
Read Full Story »

Apple, McDonald’s, Pfizer and More Dow Stocks Reporting This Week

Five of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, with most coming out on Tuesday. The Dow is closing in ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

6 Most Shorted Dow Stocks

It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or ...
Read Full Story »

15 Great Dividend Stocks Retirees Should Own in 2019

There are many types of investors in America. Whether you are in your twenties or retired, it is important to know what strategy is the best fit for your portfolio. ...
Read Full Story »

Unbelievable Swings in Big Pharma Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 5 Most Shorted Dow Stocks

It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or ...
Read Full Story »

What’s Next for Sangamo After This Hemophilia Study

Sangamo Therapeutics Inc. (NASDAQ: SGMO) shares jumped on Tuesday after the company announced interim data from its midstage hemophilia trial in collaboration with Pfizer Inc. (NYSE: PFE). The Phase 1/2 ...
Read Full Story »

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

Shares of drug giant Pfizer Inc. (NYSE: PFE) have lagged rival Merck & Co. Inc. (NYSE: PFE). The gain of 23% for Pfizer from this time a year ago is ...
Read Full Story »

Major Pharma Sees a Few Wild Swings in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Pfizer and Apple Remain Most Shorted Dow Stocks

It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or ...
Read Full Story »